Endometrial Cancer for the Nurse Practitioner Licensing Exam
Definition and Epidemiology
- Definition
- Endometrial cancer is a malignancy of the endometrium, the lining of the uterus, and is the most common gynecologic cancer in the United States.
- Main types:
- Type I (Endometrioid): Estrogen-dependent, often linked with endometrial hyperplasia.
- Type II (Non-endometrioid): Estrogen-independent, includes more aggressive types like serous and clear cell carcinoma.
- Epidemiology
- Primarily affects postmenopausal women, with peak incidence between ages 55-65.
- Increasing incidence, associated with obesity-related estrogen exposure.
Risk Factors
- Hormonal Factors:
- Unopposed Estrogen: High estrogen without progesterone promotes endometrial proliferation.
- Obesity: Increases peripheral estrogen production.
- Polycystic Ovarian Syndrome (PCOS): Chronic anovulation leads to continuous estrogen exposure.
- Genetic Factors:
- Lynch Syndrome: Increases endometrial cancer risk.
- Cowden Syndrome: Mutation in PTEN gene associated with multiple cancers.
- Other Factors:
- Early menarche, late menopause, nulliparity, and tamoxifen use.
Clinical Manifestations
- Abnormal Uterine Bleeding (AUB):
- Most common symptom, especially postmenopausal bleeding.
- In premenopausal women, may present as irregular or heavy bleeding.
- Pelvic Pain:
- Typically seen in advanced disease due to local tumor spread.
Diagnosis
- Transvaginal Ultrasound (TVUS):
- Initial imaging; endometrial thickness >4 mm in postmenopausal women warrants biopsy.
- Endometrial Biopsy:
- Gold standard for diagnosis, indicated for postmenopausal bleeding or high-risk premenopausal women with AUB.
- Hysteroscopy:
- Used for direct visualization and biopsy of focal lesions if needed.
Treatment
- Surgical Management:
- Total Hysterectomy with Bilateral Salpingo-Oophorectomy (THBSO) is standard.
- Adjuvant Therapy:
- Radiation for high-risk disease; chemotherapy for advanced or aggressive cases.
Key Points
- Endometrial Cancer is the most common gynecologic malignancy, often presenting with postmenopausal bleeding.
- Risk Factors include unopposed estrogen, obesity, PCOS, Lynch syndrome, and tamoxifen.
- Diagnosis relies on transvaginal ultrasound and endometrial biopsy.
- Treatment: THBSO is standard, with adjuvant radiation or chemotherapy for advanced stages.